Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
76.32
+2.66 (3.61%)
Nov 25, 2025, 4:00 PM EST - Market closed
Revolution Medicines Market Cap
Revolution Medicines has a market cap or net worth of $14.75 billion as of November 26, 2025. Its market cap has increased by 45.12% in one year.
Market Cap
14.75B
Enterprise Value
12.98B
1-Year Change
45.12%
Ranking
Category
Stock Price
$76.32
Market Cap Chart
Since February 13, 2020, Revolution Medicines's market cap has increased from $1.64B to $14.75B, an increase of 797.20%. That is a compound annual growth rate of 46.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 25, 2025 | 14.75B | 82.53% |
| Dec 31, 2024 | 8.08B | 71.26% |
| Dec 29, 2023 | 4.72B | 123.15% |
| Dec 30, 2022 | 2.11B | 14.03% |
| Dec 31, 2021 | 1.85B | -29.43% |
| Dec 31, 2020 | 2.63B | 59.81% |
| Feb 13, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 950.00B |
| Johnson & Johnson | 493.54B |
| AbbVie | 411.22B |
| UnitedHealth Group | 290.31B |
| AstraZeneca | 280.49B |
| Merck & Co. | 252.84B |
| Novartis AG | 243.93B |
| Abbott Laboratories | 224.64B |